Knowthestock.com
ARA - American Renal Associates Holdings, Inc.

Sell

Weak GrowthEarnings/Profit is Negative

12%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is -1.23%
Operating Income Growth is 1.81%
Net Income is Negative but improving
Earnings Per Share (EPS) is Negative
Net Margin is -1.2%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.05
Debt Ratio is 0.84
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.54
Cash Flow is MODERATE
Cash from Operations Growth is 202.16%
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
American Renal Associates Holdings, Inc. (ARA) - http://www.americanrenal.com
American Renal Associates Holdings, Inc. operates with interest in providing kidney dialysis services. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. The company was founded by Joseph A. Carlucci, Christopher T. Ford and Syed T. Kamal in 1999 and is headquartered in Beverly, MA.
Exchange - New York Stock Exchange
Industry - Medical/Nursing Services
Sector - Health Services
CEO - Joseph A. Carlucci
Employees - 4,977
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.